Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management.
about
Autonomic neuropathy in diabetes mellitusUdenafil for the treatment of erectile dysfunctionMesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus.Chronic treatment with Ang-(1-7) reverses abnormal reactivity in the corpus cavernosum and normalizes diabetes-induced changes in the protein levels of ACE, ACE2, ROCK1, ROCK2 and omega-hydroxylase in a rat model of type 1 diabetesCorrection of diabetic erectile dysfunction with adipose derived stem cells modified with the vascular endothelial growth factor gene in a rodent diabetic model.Hypoxia precondition promotes adipose-derived mesenchymal stem cells based repair of diabetic erectile dysfunction via augmenting angiogenesis and neuroprotectionImmunization associated with erectile dysfunction based on cross-sectional and genetic analyses.Antioxidant icariside II combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic ratsPreparation and clinical evaluation of nano-transferosomes for treatment of erectile dysfunction.What the radiologist needs to know about the diabetic patient.Effects of cigarette smoking on erectile dysfunctionStem Cell Therapy for Diabetic Erectile Dysfunction in Rats: A Meta-Analysis.Combination of mesenchymal stem cell injection with icariin for the treatment of diabetes-associated erectile dysfunction.ROS activates JNK-mediated autophagy to counteract apoptosis in mouse mesenchymal stem cells in vitro.Association of psychological factors, patients' knowledge, and management among patients with erectile dysfunctionAntioxidant Potential and Ability of Phloroglucinol to Decrease Formation of Advanced Glycation End Products Increase Efficacy of Sildenafil in Diabetes-Induced Sexual Dysfunction of Rats.Unproven Therapies for Diabetes and Their Implications.Therapeutic effects of adipose-derived stem cells-based microtissues on erectile dysfunction in streptozotocin-induced diabetic rats.Diabetes and sexual dysfunction: current perspectives.A review of outcomes of an intracavernosal injection therapy programme.Advanced glycation end-products: a common pathway in diabetes and age-related erectile dysfunction.Treatment strategies for diabetic patients suffering from erectile dysfunction: an update.Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitusSexual Response in Women with Type 1 Diabetes Mellitus: A Controlled Laboratory Study Measuring Vaginal Blood Flow and Subjective Sexual Arousal.Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model.Effect of phenolic acids on functions of rat aorta, vas deferens and on metabolic changes in streptozotocin-induced diabetes.A study of the early changes of the level of calcitonin gene-related Peptide and histopathology of penises of rats with experimentally induced type I diabetes mellitus by streptozocin.A coculture system of cavernous endothelial and smooth muscle cells.Effects of Next-Generation Low-Energy Extracorporeal Shockwave Therapy on Erectile Dysfunction in an Animal Model of Diabetes.Defining a glycated haemoglobin (HbA1c) level that predicts increased risk of penile implant infection.The inhibitory effects of soybean isoflavones on testicular cell apoptosis in mice with type 2 diabetes.Penile Erection Induced by Scoparone from Artemisia capillaris through the Nitric Oxide-Cyclic Guanosine Monophosphate Signaling Pathway.Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction.Differentially expressed microRNAs in the corpus cavernosum from a murine model with type 2 diabetes mellitus-associated erectile dysfunction.Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction.Association between erectile dysfunction and echocardiographic variables of ventricular hypertrophy and diastolic function in hypertensive patients with type 2 diabetes mellitus: a cross-sectional study.Role of endothelin receptors and relationship with nitric oxide synthase in impaired erectile response in diabetic rats.Icariside II prevents high-glucose-induced injury on human cavernous endothelial cells through Akt-eNOS signaling pathway.Icariside II ameliorates endothelial dysfunction by regulating the MAPK pathway via miR-126/SPRED1 in diabetic human cavernous endothelial cells.Efficient Promotion of Autophagy and Angiogenesis Using Mesenchymal Stem Cell Therapy Enhanced by the Low-Energy Shock Waves in the Treatment of Erectile Dysfunction
P2860
Q21131270-83C423AA-1EC4-4BD1-BA3C-85E3203BD665Q26851999-A18A4BE2-F869-4366-A882-C9ECA0313A03Q33719419-6875BB7D-0E52-4FD5-8275-CBE598ED3D7EQ34275725-3557850C-F608-4927-B67A-1DCF9F62CD42Q34983617-9AC71388-64FE-4297-A8DC-6879E19839B9Q35196216-F0853A23-4EF8-478D-8B5F-F57CFCA928EEQ35365403-5BE99164-F4A4-4C8F-9B20-2278669DD80BQ35571907-B6FC0C01-D6E3-47EC-B6C2-6BEB8F85C4BDQ35586217-1071D0F8-C761-46DA-87B5-BD81C17D4DDDQ35675679-1EBB1294-B441-41A2-B616-784914B130F6Q35799919-8315B3EE-0F18-45F5-836D-58074865FFEFQ35998331-A69C2E35-4142-4AE3-A5C6-DDEDDE7F7779Q36325499-603882FB-44DC-475C-AECF-15365E1A98C5Q36751925-B9E53B28-1683-4D00-A9EF-8C4AACC17A87Q36921754-2C6B1771-557D-41AD-B1D6-AAFE5D25CDC8Q37218074-4ED88F86-AEFF-4EDF-8369-250A52D182BFQ37562491-D9A94305-7CEC-482A-B9CF-1F7E09FA6660Q37581422-D6FC7F84-9A30-4644-AC51-56C986975BE0Q37630425-550B5D28-756F-4EE8-BFE2-93BABD96B69AQ38008053-4AA517F7-E2D3-48C7-B4AB-368EDC1F9B56Q38118993-EBD0597F-BBC9-4986-B9F5-255BD0294AB2Q38224353-35CC100A-FBFB-4A51-BDFA-A071C75E74E1Q38466768-85FE7CA1-3BD3-4E9A-9DB9-B6FDAC922513Q40858323-75E16ACF-082E-4781-A7C4-25E6EEE24131Q41336279-CD93FA57-097C-444D-9E8C-A342C42C2FCEQ42282748-30952707-D082-44DB-8DC8-3F949EE29DECQ42928284-DF07DC04-76A3-4000-AA04-8730D32F757BQ44472286-EB193A1C-4225-4166-ACC6-B025003B8BC0Q45874863-0479CE7E-7778-4D92-8EFA-AC915E0E4735Q46976417-68EE7DC7-2779-475C-AA03-45BCB97E2AA4Q47107873-7793A21E-233A-411C-9B5C-78A7FF6455DBQ47111265-10BE3BC3-D0CC-4492-AC84-BF5FBC8F6EF5Q50982493-9AFBCC67-36B3-4D0F-B7CF-8A46465D54B3Q51124041-A25BE33E-4DD1-4AD5-BF0F-3DFDE61794E0Q53081324-D7E3FB6D-A45D-4839-8AF1-E7C33C870468Q53096235-DFF27FC6-4954-438B-93E0-7D9AC2C6F7AEQ53108411-0E4794DB-0226-4F8B-977A-8562F8EDEEB2Q53628957-9CAB3D9D-1AF9-48D1-ADD4-04C2A9E2AFFCQ55296399-BE4CBDD9-EBE2-46D4-ADBE-89B5F04D9D4CQ57167048-E48DB316-1D38-4F9A-BDCD-AA010DB34A5E
P2860
Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management.
@en
Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management.
@nl
type
label
Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management.
@en
Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management.
@nl
prefLabel
Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management.
@en
Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management.
@nl
P2093
P1476
Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management.
@en
P2093
Ajay D Kshirsagar
Kundan G Ingale
Neeraj S Vyawahare
Reshma J Mohite
Vipin S Joshi
Vrushali S Thorve
P304
P356
10.1016/J.JDIACOMP.2010.03.003
P577
2010-05-11T00:00:00Z